BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 30681907)

  • 1. Role of gut metabolism of adrenal corticosteroids and hypertension: clues gut-cleansing antibiotics give us.
    Morris DJ; Brem AS
    Physiol Genomics; 2019 Mar; 51(3):83-89. PubMed ID: 30681907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous inhibitors (GALFs) of 11beta-hydroxysteroid dehydrogenase isoforms 1 and 2: derivatives of adrenally produced corticosterone and cortisol.
    Morris DJ; Latif SA; Hardy MP; Brem AS
    J Steroid Biochem Mol Biol; 2007 May; 104(3-5):161-8. PubMed ID: 17459698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An alternative explanation of hypertension associated with 17α-hydroxylase deficiency syndrome.
    Morris DJ; Latif SA; Brem AS
    Steroids; 2014 Jan; 79():44-8. PubMed ID: 24176792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of 11β-hydroxysteroid dehydrogenase functions by the cloud of endogenous metabolites in a local microenvironment: The glycyrrhetinic acid-like factor (GALF) hypothesis.
    Morris DJ; Brem AS; Odermatt A
    J Steroid Biochem Mol Biol; 2021 Nov; 214():105988. PubMed ID: 34464733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous selective inhibitors of 11beta-hydroxysteroid dehydrogenase isoforms 1 and 2 of adrenal origin.
    Latif SA; Pardo HA; Hardy MP; Morris DJ
    Mol Cell Endocrinol; 2005 Nov; 243(1-2):43-50. PubMed ID: 16188377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Why do humans have two glucocorticoids: A question of intestinal fortitude.
    Morris DJ
    Steroids; 2015 Oct; 102():32-8. PubMed ID: 26144050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucocorticoids and gut bacteria: "The GALF Hypothesis" in the metagenomic era.
    Morris DJ; Ridlon JM
    Steroids; 2017 Sep; 125():1-13. PubMed ID: 28624548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of ELISA Technique and Human Microsomes in the Search for 11
    Kupczyk D; Studzińska R; Bilski R; Woźniak A
    Biomed Res Int; 2019; 2019():5747436. PubMed ID: 31214617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 11beta-hydroxysteroid dehydrogenase type 1 and obesity.
    Morton NM; Seckl JR
    Front Horm Res; 2008; 36():146-164. PubMed ID: 18230901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In obese mice, exercise training increases 11β-HSD1 expression, contributing to glucocorticoid activation and suppression of pulmonary inflammation.
    Du SF; Yu Q; Chuan K; Ye CL; He ZJ; Liu SJ; Zhu XY; Liu YJ
    J Appl Physiol (1985); 2017 Oct; 123(4):717-727. PubMed ID: 28663379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local cortisol/corticosterone activation in skin physiology and pathology.
    Terao M; Katayama I
    J Dermatol Sci; 2016 Oct; 84(1):11-16. PubMed ID: 27431412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uninephrectomy reduces 11β-hydroxysteroid dehydrogenase type 1 and type 2 concomitantly with an increase in blood pressure in rats.
    Lauterburg M; Escher G; Dick B; Ackermann D; Frey FJ
    J Endocrinol; 2012 Sep; 214(3):373-80. PubMed ID: 22739210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The expression of 11β-hydroxysteroid dehydrogenase type 1 and 2 in nasal polyp-derived epithelial cells and its possible contribution to glucocorticoid activation in nasal polyp.
    Kook JH; Kim HJ; Kim KW; Park SJ; Kim TH; Lim SH; Kang SH; Lee SH
    Am J Rhinol Allergy; 2015; 29(4):246-50. PubMed ID: 26163245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 11{beta}-Hydroxysteroid dehydrogenase 2 in rat leydig cells: its role in blunting glucocorticoid action at physiological levels of substrate.
    Ge RS; Dong Q; Niu EM; Sottas CM; Hardy DO; Catterall JF; Latif SA; Morris DJ; Hardy MP
    Endocrinology; 2005 Jun; 146(6):2657-64. PubMed ID: 15761036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diet and the role of 11beta-hydroxysteroid dehydrogenase-1 on obesity.
    London E; Castonguay TW
    J Nutr Biochem; 2009 Jul; 20(7):485-93. PubMed ID: 19443197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 11beta-hydroxysteroid dehydrogenase type 1 inhibitors as promising therapeutic drugs for diabetes: status and development.
    Ge R; Huang Y; Liang G; Li X
    Curr Med Chem; 2010; 17(5):412-22. PubMed ID: 20015040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of 11β-hydroxysteroid dehydrogenase 1 and 2 in patients with chronic rhinosinusitis and their possible contribution to local glucocorticoid activation in sinus mucosa.
    Jun YJ; Park SJ; Kim TH; Lee SH; Lee KJ; Hwang SM; Lee SH
    J Allergy Clin Immunol; 2014 Oct; 134(4):926-934.e6. PubMed ID: 24810847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of 11β-hydroxysteroid dehydrogenase type 2 in human hypertension.
    Ferrari P
    Biochim Biophys Acta; 2010 Dec; 1802(12):1178-87. PubMed ID: 19909806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 11β-Hydroxysteroid dehydrogenase type 1: relevance of its modulation in the pathophysiology of obesity, the metabolic syndrome and type 2 diabetes mellitus.
    Pereira CD; Azevedo I; Monteiro R; Martins MJ
    Diabetes Obes Metab; 2012 Oct; 14(10):869-81. PubMed ID: 22321826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The hypertensiogenetic steroid 19-nor-progesterone does not influence cortisol inactivation by 11beta-hydroxysteroid dehydrogenase type 2.
    Lepenies J; Stewart PM; Quinkler M
    Clin Exp Hypertens; 2009 Jun; 31(4):376-9. PubMed ID: 19811365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.